Abstracts (HTML) List of Authors

Cai, C

Die hepatische Antwort auf LPS wird (auch) durch den zellulären cross-talk zwischen HSC und LSEC vermittelt

Calvisi, D

Hepatocellular clear cell foci after combined intraportal pancreatic islet transplantation and knockout of chREBP in diabetic mice
The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
The pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

Cameron, S

PECAM-1 mediated liver damage in a selective liver radiation model: a role for TNF-α

Canbay, A

TIPS in patients with portal hypertension – patency depends on coverage
Triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis – investigations on 565 patients

Carambia, A

T cell mediated cholangitis alters bile acid metabolism
Experimentally induced autoimmune hepatitis is initiated by formation of ectopic lymphoid tissue in the liver

Casetti, F

The role of phosphopeptide neoantigens in cancer immunotherapy

Casey, J

Efficacy of HDV mono-infection with genotype 1 and 3 in CRPISPR/Cas generated humanized NTCP mice compared to human liver chimeric mice

Casper, M

Increased prevalence of low-frequency- and rare NOD2 variants in patients with cirrhosis treated in tertiary care hepatology centers

Castoldi, M

Defining the LINC00152-modulated ceRNA network in human hepatocellular carcinoma
The liver specific microRNA-122 modulates hepatic response to infection and inflammation by antagonizing YY1, FoxP3, Nrf1 and E2F4 molecular networks

Castro, J

Dietary cholesterol promotes transition from hepatic steatosis to steatohepatitis/NASH particularly in combination with a PUFA-rich Western-type diet

Castven, D

Application of Patient-Derived Liver Cancer Cells in Personalized Treatment Approach: Phenotypic Characterization and Therapeutic Target Identification

Che, L

The pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

Chen, X

The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
The pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

Christ, B

Mesenchymale Stammzellen vermindern durch Thrombospondin 1 vermittelte Epithelschädigungen nach ausgedehnter Leberteilresektion im Schwein
Reduzierte Proliferationsraten transplantierter Hepatozyten verhindern eine effiziente Repopularisierung in seneszenten Rattenempfängerlebern

Churin, Y

Hepatozelluläre c-Jun Aktivierung durch Schistosoma mansoni Infektion im Hamster Modell
Reduktion Karzinogenese-assoziierter Signalwege durch pharmakologische Inhibierung des Cannabinoid-Rezeptor-1 im murinen Abcb4-/- Modell
Das Ausschalten des Endocannabinoid Rezeptor 1 Signalweges reduziert die hepatische Steatose im Maus Modell für Hepatitis B
IRF3/7 Double knockout enhanced progressive steatosis and inflammation during overexpression of Hepatitis B surface proteins in mice
Identifizierung der bindenden Peptidsequenz von Zytokeratin 18 an das große Hepatitis-B-Oberflächenprotein

Ciesek, S

HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations

Cigliano, A

Hepatocellular clear cell foci after combined intraportal pancreatic islet transplantation and knockout of chREBP in diabetic mice
The pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

Cobbold, M

The role of phosphopeptide neoantigens in cancer immunotherapy

Coleman, D

Dietary cholesterol promotes transition from hepatic steatosis to steatohepatitis/NASH particularly in combination with a PUFA-rich Western-type diet

Cornberg, M

Differential escape pathways from the dominant CD8 T cell epitope in HBV core18 – 27 depend on the HLA class I genotype
Einfluss von Diabetes mellitus (Typ 2) auf Inzidenz und Verlauf einer spontan bakteriellen Peritonitis bei Patienten mit Leberirrhose und Aszites
Co-morbidities and risk for drug-drug-interactions in HCV GT 1 patients treated with elbasvir/grazoprevir from the German Hepatitis C Registry (DHC-R)

Costa, I

Defining the LINC00152-modulated ceRNA network in human hepatocellular carcinoma

Coulouarn, C

SOX9 is a crucial transcription factor determining intrahepatic cholangiocarcinoma resistance to chemotherapy

Cubero, F

Bacterial translocation and inflammasome activation trigger chronic liver disease in the Mdr2-/- mouse model

Curbishley, S

The role of phosphopeptide neoantigens in cancer immunotherapy

Czauderna, C

Alpha-fetoprotein changes prior to therapy predict overall survival of patients with hepatocellular carcinomas
Application of Patient-Derived Liver Cancer Cells in Personalized Treatment Approach: Phenotypic Characterization and Therapeutic Target Identification

Czigany, Z

Hilar en-bloc resection for perihilar cholangiocarcinoma (PHCC); a single-center experience
Dunbar syndrome in liver transplantation: results of a single center matched-pair analysis and a European survey study
Comparative outcome analysis of two-stage hepatectomy with PVE (TSH/PVE) versus ALPPS for patients with colorectal liver metastases (CRLM)
Multimodal treatment modalities are associated with improved long-term outcome in patients with recurrent hepatocellular carcinoma

Czink, E

Low Frequency of Mismatch Repair Deficiency in a Large Cohort of Non-liver fluke associated Cholangiocarcinomas